| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $17.0M | +19.8% |
| SG&A Expense | $10.0M | +41.4% |
| Operating Income | -$27.0M | -26.9% |
| Net Income | -$25.7M | -84.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.7M | -54.2% |
| Current Assets | $23.1M | -51.5% |
| Total Assets | $45.8M | -10.4% |
| Current Liabilities | $5.7M | -16.1% |
| Total Liabilities | $25.0M | +267.0% |
| Stockholders' Equity | $20.8M | -53.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.7M | -26.1% |
| Capital Expenditures | $887K | +162.4% |
| Investing Cash Flow | -$887K | -162.4% |
| Financing Cash Flow | $133K | -99.8% |
| Free Cash Flow | -$24.6M | -28.6% |